Exploitation of Lectinized Lipo-Polymerosome Encapsulated Amphotericin B to Target Macrophages for Effective Chemotherapy of Visceral Leishmaniasis-Reference-Cited by-同舟云学术

Exploitation of Lectinized Lipo-Polymerosome Encapsulated Amphotericin B to Target Macrophages for Effective Chemotherapy of Visceral Leishmaniasis

Published:2014-06-09 Issue:6 Volume:25 Page:1091-1102
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Gupta Pramod K.¹,Asthana Shalini¹,Jaiswal Anil K.¹,Kumar Vivek¹,Verma Ashwni K.¹,Shukla Prashant¹,Dwivedi Pankaj¹,Dube Anuradha¹,Mishra Prabhat R.¹

Affiliation:

1. Pharmaceutics and ‡Parasitology Division, Council of Scientific and Industrial Research-Central Drug Research Institute, B 10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, India 226031

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc500087h

Reference39 articles.

1. Current diagnosis and treatment of visceral leishmaniasis

2. Drug Targeting in Cancer Therapy: The Magic Bullet, What Next?

3. Immunotoxins: An Update

4. Lectins: Cell-Agglutinating and Sugar-Specific Proteins

5. Antinutritive effects of wheat-germ agglutinin and other N-acetylglucosamine-specific lectins

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amphotericin B Pharmacokinetics: Inter-strain Differences in Rats Following Intravenous Administration of the Most Commonly Marketed Formulations of the Drug;Iranian Journal of Pharmaceutical Research;2023-03-23

2. The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis;International Journal of Pharmaceutics;2023-02

3. Current Challenges and Nanotechnology-Based Pharmaceutical Approaches for the Treatment and Control of Visceral Leishmaniasis;Recent Advances in Pharmaceutical Innovation and Research;2023

4. Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major;Molecules;2022-12-08

5. Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis – A review;Biomedicine & Pharmacotherapy;2021-09